News & Analysis on Clinical Trial Services & Contract Research And Development
Goodwin Biotechnology says making trial supplies of Q Therapeutics’ amyotrophic lateral sclerosis (ALS) cell therapy meant overcoming considerable technical hurdles.
Full-service CRO (contract research organization) Frontage Laboratories has acquired a 45% stake in BDM Consulting to expand its offerings in biostatistics, data management and SAS (statistical analysis system) programming.
Eisai has agreed to transfer ownership of its Research Triangle Park (RTP) manufacturing campus to Biogen, which will continue to manufacture oral solid-dose products and parenteral products at the sites for Eisai.
Agilent and A*STAR have partnered to create quicker, more accurate ways of testing the sugar content of therapeutic proteins and monoclonal antibodies (mAbs) that are tailored for commercial producers.